The FDA released more draft guidance with strong relevance to the stem cell field. This October 2015 new draft guidance follows about a year after three other previous draft guidances that made it clear the current FDA thinking on various issues including stromal vascular fraction (SVF; fat stem cells) was much more restrictive than generally […]
More tough FDA draft guidance on stem cells…still no action Read More »
We hear so much about exciting potential stem cell therapies, but what about stem cell treatment cost? Some of these “therapies” are rigorously evaluated ones in the FDA clinical trial pipeline and others are available right now mainly through predatory stem cell clinics. Earlier this year I posted about the cost of the offerings of
Stem cell treatment cost 2.0: legit therapy Read More »
What are the top stem cell videos on YouTube? They are not at all what I thought they would be, at least the top 20 as ranked by view count. Update for 2020: One of the top videos now is a provocative one of Joe Rogan, Mel Gibson, and a clinic operator. This video seems
Surprising 20 most popular stem cell videos on YouTube Read More »
I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the
ISSCR President Sean Morrison on challenges and future of stem cell field Read More »
Both current and former professional sports stars are lining up to get stem cell “treatments” of various kinds for all sorts of injuries and medical conditions including now Bart Starr. The aging stars who have received stem cell interventions include former San Francisco 49ers quarterback John Brodie (age 79) and more recently hockey legend, Gordie
More info on Bart Starr unproven clinic stem cell treatment Read More »
For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in
My new ‘neighbor’ in Sacramento: a fat stem cell clinic Read More »
Each year towards the end of December I make predictions for the coming year as I did for 2015. In the past I usually make a top 10 prediction list, but for this year I made 20 predictions. Admittedly some of them may have been more hopes than predictions. At mid-year today on June 30th,
How are my 20 stem cell predictions for 2015 doing? Read More »
The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical
Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »
The annual ISSCR meeting has started in Stockholm. This is always a great annual meeting both for the science and for connecting with people including new friends and colleagues as well as old friends. Another element to the meeting is the insider conversations in the halls, restaurants, and bars that tell a behind the scenes
Insider Trends on Stem Cells to Look Out for at ISSCR 2015 Stockholm Read More »
Stemedica announced it is teaming up with UC San Diego (UCSD) to do stem cell research. This fits with an increasing trend in the stem cell arena is the teaming up of clinical partners with very different backgrounds and priorities. For instance, academic institutions are more often working together with for-profit stem cell clinics. Another branch
Muddier stem cell waters: Stemedica teams up with UCSD doc? Read More »